XI’AN, China, March 20, 2025 — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a key player in providing bio-ingredient solutions for the natural, health, and personal care sectors, has announced that its patent for a natural postbiotic ingredient, designed to help regulate blood sugar, is nearing launch. The company has developed a postbiotic formula from food sources to manage glycemic levels and is expected to be available soon. This innovative product, when consumed 10-30 minutes before meals, provides targeted control of post-meal glucose spikes, reducing blood sugar increases by 15-30% within 1-3 hours after eating, as demonstrated through thorough testing.

Initial data indicates that its effectiveness rivals and even surpasses existing leading products in the market. In addition to its precision, the formula is food-safe, user-friendly, and easily incorporated into daily routines – crucial factors for high user compliance. These advantages position the solution to significantly impact the post-meal blood sugar control market and gain a substantial market share.

Yongwei Hu, Chairman of the Company, commented, “Supported by a strong IP strategy, the Company is actively pursuing global patent protection. Over the next two years, we intend to secure approvals in key markets, protecting our innovation while establishing ourselves for long-term leadership in the rapidly growing metabolic health field. This strategic action not only safeguards the technology but also prepares the business for scalable revenue growth and increased investor interest.”

About Bon Natural Life Limited (“BON”)
BON, based in the Cayman Islands, operates in the natural, health, and personal care industries. More details can be found on the Company’s website at http://www.bnlus.com.

For more information, please contact:

Cindy Liu | IR
Email: bonnatural@appchem.cn

Safe Harbor Statement

This press release includes statements that may be considered “forward-looking statements.” These statements, which are not based on historical facts, are often identified by terms like “believes,” “expects,” and similar expressions, and involve known and unknown risks and uncertainties. While the Company believes these expectations are reasonable, they are subject to assumptions, risks, and uncertainties, and may not be accurate. Readers should not rely excessively on these forward-looking statements, which are relevant only as of the release date. The Company’s actual results may differ significantly from those projected in these statements due to various factors, including those detailed in the Company’s reports filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements made by the Company or its representatives are qualified in their entirety by these factors. The Company is not obligated to update these statements unless required by securities laws.